Home » Topics » BioWorld Science

BioWorld Science
RSS

Intra-Cellular Therapies identifies new gamma-carboline derivatives

July 7, 2021

Ifenprodil will not advance into phase III trial for COVID-19

July 7, 2021

Eli Lilly and Company synthesizes GTPase KRAS mutant inhibitors

July 7, 2021

Kymera Therapeutics patents new PROTACs

July 7, 2021

Shionogi discloses new HDAC2 inhibitors

July 7, 2021

Vanderbilt University patents muscarinic M4 receptor antagonists

July 7, 2021

FDA clears IND for AGEN-1777

July 7, 2021

Positive phase I data for UBX-1325 in patients with advanced vascular eye disease

July 7, 2021

First patient dosed in phase IIb study of Lomecel-B in hypoplastic left heart syndrome

July 7, 2021

Positive interim data from phase Ib study of ARO-HIF2 in clear cell renal cell carcinoma

July 7, 2021

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...